SCHEMBL5803757

SCHEMBL5803757

O=C(c1cccc(CCl)c1)C1CNc2ccc([N+](=O)[O-])cc21

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
ALDH1A1 P00352 6/20 0.39
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
POLB P06746 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPK1 P28482 2/20 0.36
TP53 P04637 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5806059 0.88 TSHR (0.39) TSHRALDH1A1CHRNB4CHRNA3
SCHEMBL5815231 0.81 ACKR3 (0.40) ALDH1A1
SCHEMBL5803808 0.81 TSHR (0.42) TSHRALDH1A1CHRNB4CHRNA3CES2
SCHEMBL8113614 0.76 GAPDH (0.52) ALDH1A1CHRNB4CHRNA3SMN1; SMN2MAPT
SCHEMBL5806578 0.74 HTR1A (0.56)
SCHEMBL27714387 0.73 CHRNB4 (0.43) ALDH1A1CHRNB4CHRNA3
SCHEMBL6810224 0.69 AR (0.41) ALDH1A1CHRNB4CHRNA3SMN1; SMN2LMNA
SCHEMBL27596768 0.69 CHRNB4 (0.49) ALDH1A1CHRNB4CHRNA3SMN1; SMN2MAPT
SCHEMBL27821121 0.68 CHRNB4 (0.46) CHRNB4CHRNA3
SCHEMBL15544368 0.68 ALDH1A1 (0.44) ALDH1A1CHRNB4CHRNA3SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006088954-A1 DIHYDROINDOLYL METHANONES AS ALPHA 1A/1D ADRENORECEPTOR MODULATORS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY AND LOWER URINARY TRACT SYMPTOMS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-08-24 WO disclosed